4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-000960
Options or other derivatives
- CLO, CFO, Corp Sec. acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lim Bryant David CLO, CFO, Corp Sec. | 2025-02-04 | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | D | ||
Loading xslF345X05/primarydocument.xml…